Исследование углеводного обмена у больных хронической обструктивной болезнью легких

Abstract

We studied the carbohydrate metabolism in patients with chronic obstructive pulmonary disease (COPD) using glucose tolerance test (GTT) and were evaluated using this test to improve diagnosis of carbohydrate metabolism disorders (CMDS). Found that COPD patients with the exception of the risk factors listed in recommendations of who and the International diabetes Federation (IDF), GTT identifies NDU significantly more often than in the assessment of glucose of blood plasma on an empty stomach, this confirms the hypothesis put forward earlier by the authors of this work about the significant role of COPD in the pathogenesis of CMDS and in particular type 2 diabetes mellitus (DM2). This indicates the appropriateness of assigning COPD to the risk group for DM2, and, consequently, performing GTT in this cohort of patients. At the same time, GTT is a simple and fairly informative method of diagnosing CMDS and can be used as a screening method regardless of the fasting blood glucose level. It was also found that the prevalence of glucose tolerance disorders is much less common in Western Europe than in Eastern Europe, which is close to the values of our data.